Sonic Healthcare (ASX:SHL) share price struggles despite COVID passport positioning

The Sonic Healthcare share price tumbled from a record open this morning. Let's take a closer look.

| More on:
a doctor with stethoscope around neck sits as a computer with head in hand, looking despondent.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price faded its morning gains after opening 2.88% higher to a new all-time high of $43.95.

At the time of writing, shares in the medical diagnostics company are flat at $42.72.

Sonic Healthcare positioned to perform COVID-19 testing for vaccine passport

Sonic Healthcare has played a crucial role in pandemic control, performing ~30 million COVID PCT tests from March 2020 to date.

According to the Australian Financial Review (AFR), Sonic Healthcare is "positioning itself as the top contender to conduct the COVID-19 testing for an eventual "vaccine passport" if there is a government tender process".

Sonic Healthcare CEO Colin Goldschmidt told the AFR that "While there has not been any signal from the government about such a tender process, at the moment the airlines are trying to co-ordinate since they don't want COVID-19 infected travellers on the plane,".

"It's early days, but we are very much investigating what sort of role we can play in terms of travel passports, vaccination and testing, and then linking in with international air carriers. It's a big and complicated area," he said.

COVID-19 testing lifting Sonic Healthcare's earnings

Sonic Healthcare said in its FY21 results that COVID-19 testing has enhanced its financial performance.

As a result, the company's revenue increased 28% to $8.8 billion while net profit surged 149% to $1.3 billion.

Despite a strong financial performance, the Sonic Healthcare share price fell 2.76% to $41.65 on the day of the announcement.

One potential concern is the company's increasing dependency on COVID-19 testing.

Sonic Healthcare flagged that COVID-19 PCR volumes were lower in the second half of the year versus the first half, but have been increasing post-year end with the spread of the Delta variant.

Sonic Healthcare share price snapshot

The Sonic Healthcare share price is up 29.91% year-to-date and 33% in the past 12-months.

The company's shares will go ex-dividend on Tuesday 7 September for 55 cents per share. Investors can expect the dividend to be paid out on Wednesday 22 September.

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

This stock has made millions for investors over just a few months.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Has the Pro Medicus share price risen too high too quickly?

Pro Medicus shares have rocketed 173% since this time last year.

Read more »